指南与共识毛发、甲与色素性疾病

白癜风生活质量测量:欧洲皮肤病与性病学会生活质量与患者导向结局工作组立场声明及外部专家意见

Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2022-10-19

欧洲皮肤病与性病学会(EADV)生活质量与患者导向结局工作组回顾了白癜风健康相关生活质量评估工具,并与外部白癜风专家共同提出实用建议。DLQI是最常用的工具,VIS为广泛验证的白癜风特异性工具;工作组推荐使用DLQI和CDLQI,并强调亟需经过跨文化验证且证明反应性的白癜风特异性工具。

要点

  • DLQI是白癜风中最常用的健康相关生活质量工具,便于跨国结果比较。
  • EADV工作组推荐使用DLQI和CDLQI作为白癜风中的皮肤病特异性工具。
  • 亟需有效(含跨文化验证)并证明反应性的白癜风特异性工具。

核心结论

  • EADV工作组推荐使用DLQI和CDLQI作为白癜风中的皮肤病特异性工具。
  • 亟需有效(含跨文化验证)的白癜风特异性工具,可为新工具或改进现有工具,验证须包括反应性证明。

研究设计与样本

  • EADV生活质量与患者导向结局工作组成员回顾白癜风健康相关生活质量评估工具,并与外部白癜风专家(含EADV白癜风工作组代表)共同提出实用建议。

主要发现

  • DLQI是白癜风中最常用的健康相关生活质量工具,使不同国家间结果比较成为可能。
  • 识别出多个白癜风特异性工具,其中VIS是广泛验证的白癜风特异性健康相关生活质量工具,并提出了VIS-22评分的建议最小重要变化和临床解读。
  • VIS-22为在印度使用而开发,当地存在一些关于白癜风的特定文化信念。

关键数值与推荐

  • EADV生活质量与患者导向结局工作组推荐使用DLQI和CDLQI作为白癜风中的皮肤病特异性工具。
  • VIS-22评分有建议的最小重要变化和临床解读。

临床怎么用

  • EADV工作组推荐使用DLQI和CDLQI评估白癜风患者的生活质量。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Members of the European Academy of Dermatology and Venereology (EADV) Task Force on Quality of Life (QoL) and Patient Oriented Outcomes reviewed the instruments available for health-related (HR) QoL assessment in vitiligo and together with external vitiligo experts (including representatives of the EADV Vitiligo Task Force) have made practical recommendations concerning the assessment of QoL in vitiligo patients. The Dermatology Life Quality Index (DLQI) was the most frequently used HRQoL instrument, making comparison of results between different countries possible. Several vitiligo-specific instruments were identified. The vitiligo Impact Scale (VIS) is an extensively validated vitiligo-specific HRQoL instrument with proposed minimal important change and clinical interpretation for VIS-22 scores. VIS-22 was developed for use in India, where there are some specific cultural beliefs concerning vitiligo. The EADV Task Force on QoL and Patient Oriented Outcomes recommends use of the DLQI and the Children's Dermatology Life Quality Index (CDLQI) as dermatology-specific instruments in vitiligo. There is a strong need for a valid (including cross-cultural validation) vitiligo-specific instrument that can be either a new instrument or the improvement of existing instruments. This validation must include the proof of responsiveness.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Chernyshov PV, Tomas-Aragones L, Manolache L, et al. Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts. J Eur Acad Dermatol Venereol. 2022. PMID: 36259656. doi:10.1111/jdv.18593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。